Additionally, somatic mutations of ATAD5 have been found in patients with several types of cancer and a genome-wide analysis indicated that the ATAD5 locus confers enhanced susceptibility to endometrial, breast, and ovarian cancers13–15. Here, ATAD5 is linked to cancer.